Tag Archives: IPO

Do You Really Want to File for Pharma Patent Protection in Canada, India or Ecuador?

Posted on February 15, 2018 by Warren Woessner

IPO Letter Reports Weaknesses in IP Protection Around the World In a 27 page letter dated February 8, 2018 and sent to Sue Chang at the Office of the U.S. Trade Representative, the Executive Director of IPO, Mark Lauroesch, extensively … Continue reading →

Posted in Govt Policy/PTO Policy, Int'l Practice and Policy, Non-U.S. Practice | Tagged Global IP, International IP, IPO | 1 Comment

Innovation Act Stalls in the House

Posted on July 17, 2015 by Warren Woessner

Representative Goodlatte’s Innovation Act (H.R. 9) has been shelved for now, and will not receive a floor vote until September at the earlier. There is significant conflict between measures intended to deter patent trolls and the ability of non-profit institutional … Continue reading →

Posted in Patent Reform Legislation | Tagged Goodlatte, H.R. 9, intellectual property, IPO, Patent Law, patents, Warren Woessner | 1 Comment

Ignorance is Bliss – for Teva

Posted on August 4, 2014 by Warren Woessner

I did not pay much attention to the fairly recent panel decision in Bristol-Myers Squibb Co. v. Teva Pharma. USA, 757 F.3d 967 (Fed. Cir. 2014). It seemed like a fairly routine panel affirmance of the district court’s finding that … Continue reading →

Posted in Obviousness | Tagged biotechnology, biotechnology appeal, biotechnology law, biotechnology news, Bristol Myers v Teva Pharma, Federal Circuit, intellectual property, ip, IPO, Patent Law, patents, Warren Woessner | 1 Comment

Common Citation Document Launched By Trilateral Patent Offices

Posted on November 17, 2011 by Warren Woessner

This posting came with a set of presentation slides which you can find at the end of the post. The Industry Trilateral (of which IPO is a member) initially proposed a Common Citation Document (CCD). In response, the Trilateral have … Continue reading →